Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 4 of 4 for “"immunoliposome"”.

  1. Assembly, characterization and evaluation of a 3rd generation nanoparticle based drug carrier for metastatic breast cancer treatment

    … a paclitaxel loaded nanoparticle supported immunoliposome was assembled for metastatic breast cancer drug delivery. Functionalized single walled carbon nanohorn or poly(lactic-co-glycolic acid) was encapsulated in the polyethylene glycol (PEG) coated liposome for high drug loading and …

    vt Repository record for Assembly, characterization and evaluation of a 3rd generation nanoparticle based drug carrier for metastatic breast cancer treatment (opens in a new tab)

  2. Rerouting Pre-Existing Host Vaccine-Induced Immunity to wards Breast Cancer

    … tumors. We next developed a trastuzumab-based immunoliposome to test our hypothesis of redirecting host influenza-induced immunity to cancer by therapeutic delivering influenza antigens to HER2-overexpressing breast cancer cells. The HER2-targeting immunoliposome was confirmed to retain its …

    uthsc Repository record for Rerouting Pre-Existing Host Vaccine-Induced Immunity to wards Breast Cancer (opens in a new tab)

  3. Anti-Gd2 Etoposide-Loaded Immunoliposomes For The Treatment of Gd2 Positive Tumors

    … infrared spectroscopy. We examined whether these immunoliposomes were able to target cell lines expressing varying levels of surface GD2 and affect cellular proliferation. Anti-GD2 liposomes were generally targeted in a manner that correlated with GD2 expression and inhibited proliferation in cell …

    uthsc Repository record for Anti-Gd2 Etoposide-Loaded Immunoliposomes For The Treatment of Gd2 Positive Tumors (opens in a new tab)

  4. New phytopharmaceutical anti-breast cancer formulations: immunoliposomes containing extra virgin olive oil polyphenols

    … systems and, in particular, of liposomes and immunoliposomes, may be an appropriate strategy for the effective administration of these compounds. Trastuzumab targets the human epidermal growth factor receptor 2 (HER2), which is overexpressed in 20-30% of breast cancers. Using two breast cancer …

    catania Repository record for New phytopharmaceutical anti-breast cancer formulations: immunoliposomes containing extra virgin olive oil polyphenols (opens in a new tab)